Alison Hermann1, Alyson Gorun2, Abigail Benudis3. 1. Department of Psychiatry, Weill Cornell Medical Center, 315 East 62nd Street, 5th Floor, New York, NY, 10065, USA. alh9039@med.cornell.edu. 2. Department of Psychiatry, Columbia University Medical Center, New York, NY, USA. 3. Department of Psychiatry, Weill Cornell Medical Center, 315 East 62nd Street, 5th Floor, New York, NY, 10065, USA.
Abstract
PURPOSE OF REVIEW: Despite being recognized as a first-line treatment for bipolar disorder, there is still inconsistent use of lithium in perinatal populations. This article will review data regarding lithium use during the peripartum and provide management recommendations for general psychiatric clinicians. RECENT FINDINGS: In contrast to prior data, recent studies indicate that lithium use in pregnancy is associated with either no increased malformations risk or a small increase in risk for cardiac malformations including Ebstein's anomaly. Limited data also show no significant effect on obstetric or neurodevelopmental outcomes. Data regarding infant lithium exposure via breastmilk remains limited. Lithium is currently under-prescribed and is an important treatment for women with bipolar disorder in pregnancy and the postpartum. Clinicians must weigh the risk of lithium treatment versus the risk of withholding or changing lithium treatment when managing bipolar disorder in this population.
PURPOSE OF REVIEW: Despite being recognized as a first-line treatment for bipolar disorder, there is still inconsistent use of lithium in perinatal populations. This article will review data regarding lithium use during the peripartum and provide management recommendations for general psychiatric clinicians. RECENT FINDINGS: In contrast to prior data, recent studies indicate that lithium use in pregnancy is associated with either no increased malformations risk or a small increase in risk for cardiac malformations including Ebstein's anomaly. Limited data also show no significant effect on obstetric or neurodevelopmental outcomes. Data regarding infantlithium exposure via breastmilk remains limited. Lithium is currently under-prescribed and is an important treatment for women with bipolar disorder in pregnancy and the postpartum. Clinicians must weigh the risk of lithium treatment versus the risk of withholding or changing lithium treatment when managing bipolar disorder in this population.
Authors: Veerle Bergink; Karin M Burgerhout; Kathelijne M Koorengevel; Astrid M Kamperman; Witte J Hoogendijk; Mijke P Lambregtse-van den Berg; Steven A Kushner Journal: Am J Psychiatry Date: 2015-02-01 Impact factor: 18.112
Authors: Rebecca F McKnight; Marc Adida; Katie Budge; Sarah Stockton; Guy M Goodwin; John R Geddes Journal: Lancet Date: 2012-01-20 Impact factor: 79.321
Authors: Isabella Pacchiarotti; Jordi León-Caballero; Andrea Murru; Norma Verdolini; Maria Antonietta Furio; Corinna Pancheri; Marc Valentí; Ludovic Samalin; Eva Solé Roigé; Ana González-Pinto; Jose Manuel Montes; Antonio Benabarre; Jose Manuel Crespo; Consuelo de Dios Perrino; Jose Manuel Goikolea; Luis Gutiérrez-Rojas; André F Carvalho; Eduard Vieta Journal: Eur Neuropsychopharmacol Date: 2016-08-24 Impact factor: 4.600
Authors: Javier Conejo-Galindo; Alejandro Sanz-Giancola; Miguel Ángel Álvarez-Mon; Miguel Á Ortega; Luis Gutiérrez-Rojas; Guillermo Lahera Journal: J Clin Med Date: 2022-07-08 Impact factor: 4.964
Authors: Andrea Gehrmann; Katrin Fiedler; Anna Linda Leutritz; Carolin Koreny; Sarah Kittel-Schneider Journal: Medicina (Kaunas) Date: 2021-06-18 Impact factor: 2.430